NASDAQ:XENE | Roast Me | Xenon Pharmaceuticals Inc.

37/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.

Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.

QuarterTotal returnRevenue growthEPS growthNet marginNon-scoringTrailing P/ENon-scoringPrice/bookNon-scoringCEO quarterly payNon-scoringImplied DilutionNon-scoringImplied BuybackNon-scoring
2026-Q20/3 LoseXENE / S&P
3.80% / 15.20%
LoseXENE / S&P
-100.00% / 15.00%
LoseXENE / S&P
33.52% / 50.40%
Non-scoringXENE / S&P
XENE unavailable / 15.70%
Non-scoringXENE / S&P
XENE unavailable / 28.47
Non-scoringXENE / S&P
4.70 / S&P unavailable
Non-scoringXENE / S&P
XENE unavailable / S&P unavailable
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.36b
2026-Q12/3 WinXENE / S&P
29.74% / -4.33%
LoseXENE / S&P
-100.00% / 11.30%
WinXENE / S&P
45.51% / 27.70%
Non-scoringXENE / S&P
XENE unavailable / 14.80%
Non-scoringXENE / S&P
XENE unavailable / 25.43
Non-scoringXENE / S&P
4.20 / S&P unavailable
Non-scoringXENE / S&P
XENE unavailable / S&P unavailable
Non-scoringXENE / S&P
XENE unavailable / $0.27b
Non-scoringXENE / S&P
XENE unavailable / $0.00b
2025-Q42/3 WinXENE / S&P
11.63% / 2.65%
LoseXENE / S&P
XENE unavailable / 9.00%
WinXENE / S&P
44.37% / 13.40%
Non-scoringXENE / S&P
-4612.13% / 13.20%
Non-scoringXENE / S&P
XENE unavailable / 28.48
Non-scoringXENE / S&P
6.16 / 5.39
Non-scoringXENE / S&P
XENE unavailable / $4.42m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.20b
2025-Q32/3 WinXENE / S&P
28.27% / 8.12%
LoseXENE / S&P
XENE unavailable / 4.61%
WinXENE / S&P
37.94% / 13.45%
Non-scoringXENE / S&P
-4084.45% / 11.78%
Non-scoringXENE / S&P
XENE unavailable / 28.13
Non-scoringXENE / S&P
5.53 / 5.27
Non-scoringXENE / S&P
XENE unavailable / $4.42m
Non-scoringXENE / S&P
XENE unavailable / $0.11b
Non-scoringXENE / S&P
XENE unavailable / $0.00b
2025-Q21/3 LoseXENE / S&P
-6.71% / 10.94%
LoseXENE / S&P
XENE unavailable / 4.83%
WinXENE / S&P
29.56% / 10.63%
Non-scoringXENE / S&P
-3709.71% / 11.45%
Non-scoringXENE / S&P
XENE unavailable / 27.10
Non-scoringXENE / S&P
3.80 / 5.01
Non-scoringXENE / S&P
XENE unavailable / $4.42m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.23b
2025-Q11/3 LoseXENE / S&P
-14.41% / -4.27%
LoseXENE / S&P
XENE unavailable / 4.98%
WinXENE / S&P
19.19% / 10.57%
Non-scoringXENE / S&P
-3352.61% / 11.39%
Non-scoringXENE / S&P
XENE unavailable / 26.23
Non-scoringXENE / S&P
3.65 / 4.69
Non-scoringXENE / S&P
XENE unavailable / $4.42m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.10b
2024-Q41/3 LoseXENE / S&P
-0.43% / 2.41%
LoseXENE / S&P
XENE unavailable / 5.25%
WinXENE / S&P
11.03% / 6.15%
Non-scoringXENE / S&P
XENE unavailable / 11.29%
Non-scoringXENE / S&P
XENE unavailable / 28.60
Non-scoringXENE / S&P
3.97 / 4.99
Non-scoringXENE / S&P
XENE unavailable / $4.28m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.08b
2024-Q31/3 LoseXENE / S&P
0.97% / 5.89%
LoseXENE / S&P
XENE unavailable / 5.89%
WinXENE / S&P
6.42% / 6.11%
Non-scoringXENE / S&P
XENE unavailable / 10.87%
Non-scoringXENE / S&P
XENE unavailable / 28.09
Non-scoringXENE / S&P
3.74 / 4.94
Non-scoringXENE / S&P
XENE unavailable / $4.28m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.21b
2024-Q21/3 LoseXENE / S&P
-9.43% / 4.28%
LoseXENE / S&P
XENE unavailable / 5.38%
WinXENE / S&P
10.04% / 5.12%
Non-scoringXENE / S&P
XENE unavailable / 10.85%
Non-scoringXENE / S&P
XENE unavailable / 27.64
Non-scoringXENE / S&P
3.50 / 4.79
Non-scoringXENE / S&P
XENE unavailable / $4.28m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.36b
2024-Q11/3 LoseXENE / S&P
-6.53% / 10.56%
LoseXENE / S&P
XENE unavailable / 5.71%
WinXENE / S&P
16.81% / 5.59%
Non-scoringXENE / S&P
XENE unavailable / 10.81%
Non-scoringXENE / S&P
XENE unavailable / 27.02
Non-scoringXENE / S&P
3.66 / 4.71
Non-scoringXENE / S&P
XENE unavailable / $4.28m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.12b
2023-Q42/3 WinXENE / S&P
34.84% / 11.69%
LoseXENE / S&P
XENE unavailable / 6.81%
WinXENE / S&P
33.33% / 7.78%
Non-scoringXENE / S&P
XENE unavailable / 11.19%
Non-scoringXENE / S&P
XENE unavailable / 24.35
Non-scoringXENE / S&P
3.74 / 4.31
Non-scoringXENE / S&P
XENE unavailable / $4.08m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.01b
2023-Q31/3 LoseXENE / S&P
-11.27% / -3.27%
LoseXENE / S&P
XENE unavailable / 7.52%
WinXENE / S&P
35.90% / -5.03%
Non-scoringXENE / S&P
XENE unavailable / 10.84%
Non-scoringXENE / S&P
XENE unavailable / 23.93
Non-scoringXENE / S&P
3.49 / 3.98
Non-scoringXENE / S&P
XENE unavailable / $4.08m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.24b
2023-Q21/3 LoseXENE / S&P
7.57% / 8.74%
LoseXENE / S&P
XENE unavailable / 9.50%
WinXENE / S&P
43.10% / -8.57%
Non-scoringXENE / S&P
XENE unavailable / 10.88%
Non-scoringXENE / S&P
XENE unavailable / 24.01
Non-scoringXENE / S&P
3.79 / 4.19
Non-scoringXENE / S&P
XENE unavailable / $4.08m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.17b
2023-Q11/3 LoseXENE / S&P
-9.23% / 7.50%
LoseXENE / S&P
XENE unavailable / 10.77%
WinXENE / S&P
36.47% / -15.69%
Non-scoringXENE / S&P
XENE unavailable / 10.82%
Non-scoringXENE / S&P
XENE unavailable / 22.66
Non-scoringXENE / S&P
3.29 / 3.93
Non-scoringXENE / S&P
XENE unavailable / $4.08m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.13b
2022-Q41/3 WinXENE / S&P
9.22% / 7.56%
LoseXENE / S&P
-48.83% / 11.88%
LoseXENE / S&P
XENE unavailable / -17.99%
Non-scoringXENE / S&P
-1328.95% / 11.09%
Non-scoringXENE / S&P
XENE unavailable / 22.65
Non-scoringXENE / S&P
3.42 / 3.75
Non-scoringXENE / S&P
XENE unavailable / $3.70m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.15b
2022-Q31/3 WinXENE / S&P
18.67% / -4.88%
LoseXENE / S&P
-33.65% / 13.47%
LoseXENE / S&P
XENE unavailable / -1.41%
Non-scoringXENE / S&P
-862.06% / 12.28%
Non-scoringXENE / S&P
XENE unavailable / 20.58
Non-scoringXENE / S&P
3.00 / 3.60
Non-scoringXENE / S&P
XENE unavailable / $3.70m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.17b
2022-Q22/3 WinXENE / S&P
-0.49% / -16.10%
WinXENE / S&P
15.77% / 13.71%
LoseXENE / S&P
XENE unavailable / 11.04%
Non-scoringXENE / S&P
-433.95% / 13.03%
Non-scoringXENE / S&P
XENE unavailable / 20.28
Non-scoringXENE / S&P
2.41 / 3.78
Non-scoringXENE / S&P
XENE unavailable / $3.70m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.17b
2022-Q11/3 WinXENE / S&P
-2.14% / -4.60%
LoseXENE / S&P
-22.42% / 15.97%
LoseXENE / S&P
XENE unavailable / 42.23%
Non-scoringXENE / S&P
-362.39% / 14.22%
Non-scoringXENE / S&P
XENE unavailable / 22.19
Non-scoringXENE / S&P
2.99 / 4.51
Non-scoringXENE / S&P
XENE unavailable / $3.70m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.20b
2021-Q41/3 WinXENE / S&P
104.45% / 11.03%
LoseXENE / S&P
-42.68% / 15.00%
LoseXENE / S&P
XENE unavailable / 96.40%
Non-scoringXENE / S&P
-427.85% / 15.13%
Non-scoringXENE / S&P
XENE unavailable / 23.63
Non-scoringXENE / S&P
2.93 / 4.73
Non-scoringXENE / S&P
XENE unavailable / $3.63m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.13b
2021-Q30/3 LoseXENE / S&P
-17.94% / 0.58%
LoseXENE / S&P
-34.59% / 10.77%
LoseXENE / S&P
XENE unavailable / 69.42%
Non-scoringXENE / S&P
-330.69% / 14.13%
Non-scoringXENE / S&P
XENE unavailable / 25.35
Non-scoringXENE / S&P
2.54 / 4.38
Non-scoringXENE / S&P
XENE unavailable / $3.63m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.19b
2021-Q20/3 LoseXENE / S&P
4.02% / 8.55%
LoseXENE / S&P
-33.02% / 6.58%
LoseXENE / S&P
XENE unavailable / 51.81%
Non-scoringXENE / S&P
-323.04% / 13.34%
Non-scoringXENE / S&P
XENE unavailable / 26.70
Non-scoringXENE / S&P
2.98 / 4.43
Non-scoringXENE / S&P
XENE unavailable / $3.63m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.11b
2021-Q11/3 WinXENE / S&P
16.38% / 6.17%
LoseXENE / S&P
XENE unavailable / -1.06%
LoseXENE / S&P
XENE unavailable / 7.39%
Non-scoringXENE / S&P
-126.05% / 11.60%
Non-scoringXENE / S&P
XENE unavailable / 30.50
Non-scoringXENE / S&P
2.65 / 4.23
Non-scoringXENE / S&P
XENE unavailable / $3.63m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.10b
2020-Q41/3 WinXENE / S&P
38.93% / 12.15%
LoseXENE / S&P
XENE unavailable / -3.72%
LoseXENE / S&P
XENE unavailable / -33.42%
Non-scoringXENE / S&P
-89.65% / 8.86%
Non-scoringXENE / S&P
XENE unavailable / 39.26
Non-scoringXENE / S&P
3.14 / 4.05
Non-scoringXENE / S&P
XENE unavailable / $3.17m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.01b
2020-Q30/3 LoseXENE / S&P
-11.72% / 8.93%
LoseXENE / S&P
XENE unavailable / -2.04%
LoseXENE / S&P
XENE unavailable / -27.10%
Non-scoringXENE / S&P
-91.91% / 9.24%
Non-scoringXENE / S&P
XENE unavailable / 34.27
Non-scoringXENE / S&P
2.13 / 3.65
Non-scoringXENE / S&P
XENE unavailable / $3.17m
Non-scoringXENE / S&P
XENE unavailable / $0.02b
Non-scoringXENE / S&P
XENE unavailable / $0.00b
2020-Q20/3 LoseXENE / S&P
10.58% / 20.54%
LoseXENE / S&P
XENE unavailable / -0.46%
LoseXENE / S&P
XENE unavailable / -27.11%
Non-scoringXENE / S&P
-102.25% / 9.37%
Non-scoringXENE / S&P
XENE unavailable / 31.29
Non-scoringXENE / S&P
2.32 / 3.44
Non-scoringXENE / S&P
XENE unavailable / $3.17m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.03b
2020-Q11/3 WinXENE / S&P
-13.50% / -19.60%
LoseXENE / S&P
XENE unavailable / 3.47%
LoseXENE / S&P
XENE unavailable / -14.75%
Non-scoringXENE / S&P
XENE unavailable / 10.68%
Non-scoringXENE / S&P
XENE unavailable / 22.80
Non-scoringXENE / S&P
2.11 / 2.92
Non-scoringXENE / S&P
XENE unavailable / $3.17m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.05b
2019-Q41/3 WinXENE / S&P
45.50% / 9.07%
LoseXENE / S&P
XENE unavailable / 5.36%
LoseXENE / S&P
XENE unavailable / 2.99%
Non-scoringXENE / S&P
XENE unavailable / 12.81%
Non-scoringXENE / S&P
XENE unavailable / 22.78
Non-scoringXENE / S&P
4.01 / 3.53
Non-scoringXENE / S&P
XENE unavailable / $3.08m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.05b
2019-Q30/3 LoseXENE / S&P
-8.62% / 1.70%
LoseXENE / S&P
XENE unavailable / 5.02%
LoseXENE / S&P
XENE unavailable / 0.21%
Non-scoringXENE / S&P
XENE unavailable / 12.41%
Non-scoringXENE / S&P
XENE unavailable / 22.44
Non-scoringXENE / S&P
3.13 / 3.30
Non-scoringXENE / S&P
XENE unavailable / $3.08m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.09b
2019-Q21/3 LoseXENE / S&P
-2.95% / 4.30%
LoseXENE / S&P
XENE unavailable / 6.64%
WinXENE / S&P
11.04% / 8.65%
Non-scoringXENE / S&P
XENE unavailable / 12.79%
Non-scoringXENE / S&P
XENE unavailable / 21.37
Non-scoringXENE / S&P
3.07 / 3.32
Non-scoringXENE / S&P
XENE unavailable / $3.08m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.27b
2019-Q12/3 WinXENE / S&P
61.01% / 13.65%
LoseXENE / S&P
XENE unavailable / 8.12%
WinXENE / S&P
19.33% / 14.29%
Non-scoringXENE / S&P
XENE unavailable / 12.97%
Non-scoringXENE / S&P
XENE unavailable / 20.86
Non-scoringXENE / S&P
2.84 / 3.26
Non-scoringXENE / S&P
XENE unavailable / $3.08m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $34.35b
2018-Q40/3 LoseXENE / S&P
-52.20% / -13.52%
LoseXENE / S&P
XENE unavailable / 9.05%
LoseXENE / S&P
-8.14% / 18.23%
Non-scoringXENE / S&P
XENE unavailable / 13.10%
Non-scoringXENE / S&P
XENE unavailable / 19.39
Non-scoringXENE / S&P
1.57 / 2.94
Non-scoringXENE / S&P
XENE unavailable / $3.00m
Non-scoringXENE / S&P
XENE unavailable / $0.01b
Non-scoringXENE / S&P
XENE unavailable / $0.00b
2018-Q31/3 WinXENE / S&P
43.48% / 7.71%
LoseXENE / S&P
XENE unavailable / 10.21%
LoseXENE / S&P
9.43% / 19.06%
Non-scoringXENE / S&P
XENE unavailable / 13.01%
Non-scoringXENE / S&P
XENE unavailable / 22.25
Non-scoringXENE / S&P
2.99 / 3.45
Non-scoringXENE / S&P
XENE unavailable / $3.00m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.17b
2018-Q21/3 WinXENE / S&P
87.76% / 3.43%
LoseXENE / S&P
XENE unavailable / 9.03%
LoseXENE / S&P
-7.78% / 14.46%
Non-scoringXENE / S&P
XENE unavailable / 12.56%
Non-scoringXENE / S&P
XENE unavailable / 22.49
Non-scoringXENE / S&P
3.21 / 3.25
Non-scoringXENE / S&P
XENE unavailable / $3.00m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.19b
2018-Q11/3 WinXENE / S&P
73.45% / -0.76%
LoseXENE / S&P
XENE unavailable / 7.68%
LoseXENE / S&P
-10.71% / 12.46%
Non-scoringXENE / S&P
XENE unavailable / 12.27%
Non-scoringXENE / S&P
XENE unavailable / 23.41
Non-scoringXENE / S&P
2.44 / 3.17
Non-scoringXENE / S&P
XENE unavailable / $3.00m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.08b
2017-Q41/3 LoseXENE / S&P
-4.24% / 6.64%
LoseXENE / S&P
-82.75% / 7.03%
WinXENE / S&P
16.22% / 13.82%
Non-scoringXENE / S&P
-9872.67% / 12.09%
Non-scoringXENE / S&P
XENE unavailable / 24.25
Non-scoringXENE / S&P
1.41 / 3.23
Non-scoringXENE / S&P
XENE unavailable / $2.92m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.05b
2017-Q30/3 LoseXENE / S&P
-6.35% / 4.48%
LoseXENE / S&P
-85.58% / 5.68%
LoseXENE / S&P
11.19% / 17.57%
Non-scoringXENE / S&P
-4268.70% / 12.04%
Non-scoringXENE / S&P
XENE unavailable / 23.28
Non-scoringXENE / S&P
1.23 / 3.08
Non-scoringXENE / S&P
XENE unavailable / $2.92m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.11b
2017-Q21/3 LoseXENE / S&P
-21.25% / 3.09%
LoseXENE / S&P
-90.39% / 4.83%
WinXENE / S&P
40.34% / 17.74%
Non-scoringXENE / S&P
-3489.63% / 11.96%
Non-scoringXENE / S&P
XENE unavailable / 23.40
Non-scoringXENE / S&P
1.12 / 3.03
Non-scoringXENE / S&P
XENE unavailable / $2.92m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.08b
2017-Q11/3 LoseXENE / S&P
-48.05% / 6.07%
LoseXENE / S&P
-89.99% / 3.67%
WinXENE / S&P
100.00% / 13.32%
Non-scoringXENE / S&P
-2237.36% / 11.75%
Non-scoringXENE / S&P
XENE unavailable / 23.60
Non-scoringXENE / S&P
1.26 / 3.01
Non-scoringXENE / S&P
XENE unavailable / $2.92m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $20.24b
2016-Q40/3 LoseXENE / S&P
-4.94% / 3.82%
LoseXENE / S&P
-88.43% / 2.09%
LoseXENE / S&P
XENE unavailable / 7.05%
Non-scoringXENE / S&P
-1275.49% / 11.37%
Non-scoringXENE / S&P
XENE unavailable / 23.76
Non-scoringXENE / S&P
2.16 / 2.91
Non-scoringXENE / S&P
XENE unavailable / $2.88m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $1.11b
2016-Q31/3 WinXENE / S&P
37.29% / 3.85%
LoseXENE / S&P
-72.99% / 0.20%
LoseXENE / S&P
XENE unavailable / -3.15%
Non-scoringXENE / S&P
-449.72% / 10.82%
Non-scoringXENE / S&P
XENE unavailable / 24.22
Non-scoringXENE / S&P
2.09 / 2.78
Non-scoringXENE / S&P
XENE unavailable / $2.88m
Non-scoringXENE / S&P
XENE unavailable / $0.00b
Non-scoringXENE / S&P
XENE unavailable / $0.16b

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricXENE total returnS&P 500 Total Return Index
Total return59.98%20.78%
Annualized return59.98%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricXENE total returnS&P 500 Total Return Index
Total return241.21%83.14%
Annualized return27.82%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricXENE total returnS&P 500 Total Return Index
Total return677.04%319.30%
Annualized return22.76%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring
Net margin, P/E, P/B and other gray context columns never enter the score.

Snapshot captured 2026-09-04.

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.